Aravind Asokan

Asokan

Professor in Surgery

Synthetic Virology & Gene Therapy

Appointments and Affiliations

  • Professor in Surgery
  • Director of Gene Therapy
  • Professor of Biomedical Engineering
  • Professor of Molecular Genetics and Microbiology
  • Affiliate of the Regeneration Next Initiative

Contact Information

Education

  • Ph.D. University of North Carolina - Chapel Hill, 2004

Research Interests

Virology
RNA Biology
Viral Engineering
RNA Engineering
Gene Therapy
Gene Editing
Gene Regulation
Regenerative Medicine

Courses Taught

  • MGM 293: Research Independent Study I
  • MGM 593: Research Independent Study

Representative Publications

  • Havlik, LP; Das, A; Mietzsch, M; Oh, DK; Ark, J; McKenna, R; Agbandje-McKenna, M; Asokan, A, Receptor switching in newly evolved adeno-associated viruses., J Virol (2021) [10.1128/JVI.00587-21] [abs].
  • Gibson, RA; Lim, J-A; Choi, SJ; Flores, L; Clinton, L; Bali, D; Young, S; Asokan, A; Sun, B; Kishnani, PS, Characterization of liver GSD IX γ2 pathophysiology in a novel Phkg2-/- mouse model., Mol Genet Metab, vol 133 no. 3 (2021), pp. 269-276 [10.1016/j.ymgme.2021.05.008] [abs].
  • Mitchell-Dick, A; Asokan, A, AAV-CNS matters turn from gray to white., Molecular Therapy : the Journal of the American Society of Gene Therapy, vol 29 no. 5 (2021), pp. 1659-1660 [10.1016/j.ymthe.2021.04.012] [abs].
  • Hunanyan, AS; Kantor, B; Puranam, RS; Elliott, C; McCall, A; Dhindsa, J; Pagadala, P; Wallace, K; Poe, J; Gunduz, T; Asokan, A; Koeberl, DD; ElMallah, MK; Mikati, MA, Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3Mashl/+, Mouse Model of Alternating Hemiplegia of Childhood., Hum Gene Ther, vol 32 no. 7-8 (2021), pp. 405-419 [10.1089/hum.2020.191] [abs].
  • Saha, K; Sontheimer, EJ; Brooks, PJ; Dwinell, MR; Gersbach, CA; Liu, DR; Murray, SA; Tsai, SQ; Wilson, RC; Anderson, DG; Asokan, A; Banfield, JF; Bankiewicz, KS; Bao, G; Bulte, JWM; Bursac, N; Campbell, JM; Carlson, DF; Chaikof, EL; Chen, Z-Y; Cheng, RH; Clark, KJ; Curiel, DT; Dahlman, JE; Deverman, BE; Dickinson, ME; Doudna, JA; Ekker, SC; Emborg, ME; Feng, G; Freedman, BS; Gamm, DM; Gao, G; Ghiran, IC; Glazer, PM; Gong, S; Heaney, JD; Hennebold, JD; Hinson, JT; Khvorova, A; Kiani, S; Lagor, WR; Lam, KS; Leong, KW; Levine, JE; Lewis, JA; Lutz, CM; Ly, DH; Maragh, S; McCray, PB; McDevitt, TC; Mirochnitchenko, O; Morizane, R; Murthy, N; Prather, RS; Ronald, JA; Roy, S; Roy, S; Sabbisetti, V; Saltzman, WM; Santangelo, PJ; Segal, DJ; Shimoyama, M; Skala, MC; Tarantal, AF; Tilton, JC; Truskey, GA; Vandsburger, M; Watts, JK; Wells, KD; Wolfe, SA; Xu, Q; Xue, W; Yi, G; Zhou, J; SCGE Consortium,, The NIH Somatic Cell Genome Editing program., Nature, vol 592 no. 7853 (2021), pp. 195-204 [10.1038/s41586-021-03191-1] [abs].